1. Home
  2. ROIV vs AM Comparison

ROIV vs AM Comparison

Compare ROIV & AM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROIV
  • AM
  • Stock Information
  • Founded
  • ROIV 2014
  • AM 2013
  • Country
  • ROIV United Kingdom
  • AM United States
  • Employees
  • ROIV N/A
  • AM N/A
  • Industry
  • ROIV Biotechnology: Pharmaceutical Preparations
  • AM Natural Gas Distribution
  • Sector
  • ROIV Health Care
  • AM Utilities
  • Exchange
  • ROIV Nasdaq
  • AM Nasdaq
  • Market Cap
  • ROIV 8.4B
  • AM 8.8B
  • IPO Year
  • ROIV N/A
  • AM 2014
  • Fundamental
  • Price
  • ROIV $10.94
  • AM $18.50
  • Analyst Decision
  • ROIV Buy
  • AM Hold
  • Analyst Count
  • ROIV 4
  • AM 2
  • Target Price
  • ROIV $17.50
  • AM $16.50
  • AVG Volume (30 Days)
  • ROIV 5.5M
  • AM 2.5M
  • Earning Date
  • ROIV 05-29-2025
  • AM 04-30-2025
  • Dividend Yield
  • ROIV N/A
  • AM 4.87%
  • EPS Growth
  • ROIV N/A
  • AM 8.49
  • EPS
  • ROIV N/A
  • AM 0.87
  • Revenue
  • ROIV $122,585,000.00
  • AM $1,188,943,000.00
  • Revenue This Year
  • ROIV N/A
  • AM $0.69
  • Revenue Next Year
  • ROIV N/A
  • AM $2.45
  • P/E Ratio
  • ROIV N/A
  • AM $21.42
  • Revenue Growth
  • ROIV 140.04
  • AM 5.03
  • 52 Week Low
  • ROIV $8.73
  • AM $13.12
  • 52 Week High
  • ROIV $13.06
  • AM $19.04
  • Technical
  • Relative Strength Index (RSI)
  • ROIV 52.64
  • AM 61.68
  • Support Level
  • ROIV $10.58
  • AM $18.73
  • Resistance Level
  • ROIV $11.07
  • AM $19.04
  • Average True Range (ATR)
  • ROIV 0.32
  • AM 0.33
  • MACD
  • ROIV -0.04
  • AM 0.06
  • Stochastic Oscillator
  • ROIV 33.64
  • AM 69.32

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About AM Antero Midstream Corporation

Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin located in West Virginia and Ohio. The company has two operating segments; the Gathering and Processing segment includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio and the Water Handling segment includes two independent systems that deliver water from sources including the Ohio River, local reservoirs and several regional waterways. It derives a majority of its revenue from the Gathering and Processing segment.

Share on Social Networks: